
Great Lakes Discoveries
Great Lakes Discoveries: Pioneering translational research and therapeutic treatments for systemic inflammation.

Great Lakes Discoveries: Pioneering translational research and therapeutic treatments for systemic inflammation.
Great Lakes Discoveries was founded through a partnership between the University of Michigan and Deerfield Management, a healthcare investment firm. The company is dedicated to advancing translational research and developing therapeutic treatments, particularly targeting systemic inflammation. Its core mission is to bridge the gap between preclinical research and commercial clinical development, thereby addressing unmet medical needs. Great Lakes Discoveries focuses on exploratory biologics to create innovative healthcare solutions.
Notable affiliations include the University of Michigan, a leading research institution, and Deerfield Management, which has committed significant funding to support the company's initiatives. Key achievements include securing up to $130 million in investment over the next decade to propel biomedical research at the University of Michigan. The impact of Great Lakes Discoveries lies in its potential to transform promising scientific discoveries into viable treatments, thereby improving patient outcomes and advancing the field of medical research.
Companies similar to Great Lakes Discoveries include Lakeside Discovery, Ancora Innovation, Tetra Discovery and Michigan Institute for Clinical & Health Research.
Great Lakes Discoveries was founded in 2020.
Great Lakes Discoveries' headquarters is located in New York City, NY, US.
Great Lakes Discoveries' most recent funding round was for $130M (USD) in May 2020.
As of May 27, 2020, Great Lakes Discoveries has disclosed funding of $130M (USD). Undisclosed round amounts are excluded.
Great Lakes Discoveries has 5 employees as of Feb 4, 2024.
Michigan Institute for Clinical & Health Research
michr.umich.edu